Top 20 List GMV, page-93

Hi Glyco couldn't agree more that this share price is being targeted and manipulated to accommodate individuals and or companies.

From a shareholders prospectus, it is very annoying to see the SP rise on such good volume with excellent
movement and perfect charting to support a rally and then for it to be dragged back down again.

The last consolidation at the $0.295 level on Mar 1st saw the Buy/Sell support which was confirmed with a rally upwards to $0.38.

How or why does a share price give so many positive indicators only to be knee capped and spend the next 10 days plummeting back down, and below the previous low. This stock is not acting or performing the way a stock should once it has consolidated and started a positive trend upwards. We might as well just throw the baby out with the bath water and forget about normalised trading strategies.

The only reason that I feel comfortable holding this stock at the moment, is the fact that I have Long Term confidence with management and the opportunities that await this fantastic medical company.

I'm not sure if the number of shares on issue and the future number of shares to be issued have been raised. I think that the number of shares to be issued are going to dilute the value of the company going forward with regard to EPS.
It seems an awful lot of shares to be issued willy nilly for basically the staff doing what their paid for.

As previously mentioned, I have an enormous amount confidence in this company.
I have been doing day trading full time for the last 20 years and I have never, never, never seen a company such as GMV who have a mind boggling amount of future profits. Not only do they have MOU's in place for upwards of 1 billion in sales for the Prizma sleeve, but they also have future profits that will be generated from the Patch.
When you include the revenue from the patch once patients leave the hospital, the income stream will generates massive profits.

I can only see blue sky for this company once the CFDA issue the approval (end of Mar to mid Apr) for the GMV suite of products.
Hopefully we will see 2mths of revenue for this financial year and then a more accurate form of financials going forward.
This would provide a re-rating of the share price and then to top it all off, a profit upgrade somewhere close to Sept 2018 will send it into orbit.

Cheers